Heparan sulfate proteoglycans (HSPGs) and chondroitin sulfate proteoglycans (CSPGs) function as endocytic receptors for an internalizing anti-nucleic acid antibody-Reference-Cited by-同舟云学术

Heparan sulfate proteoglycans (HSPGs) and chondroitin sulfate proteoglycans (CSPGs) function as endocytic receptors for an internalizing anti-nucleic acid antibody

Published:2017-10-30 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Park Hyunjoon,Kim Minjae,Kim Hye-Jin,Lee Yeonjin,Seo Youngsil,Pham Chuong D.,Lee Joungmin,Byun Sung June,Kwon Myung-Hee^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14793-z.pdf

Reference43 articles.

1. Prydz, K. & Dalen, K. T. Synthesis and sorting of proteoglycans. J. Cell Sci. 113(Pt 2), 193–205 (2000).

2. Rabenstein, D. L. Heparin and heparan sulfate: structure and function. Nat Prod Rep 19, 312–331 (2002).

3. Sarrazin, S., Lamanna, W. C. & Esko, J. D. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol 3, https://doi.org/10.1101/cshperspect.a004952 (2011).

4. Pantazaka, E. & Papadimitriou, E. Chondroitin sulfate-cell membrane effectors as regulators of growth factor-mediated vascular and cancer cell migration. Biochim. Biophys. Acta. https://doi.org/10.1016/j.bbagen.2014.01.009 (2014).

5. Bernfield, M. et al. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729–777, https://doi.org/10.1146/annurev.biochem.68.1.729 (1999).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell surface RNA virus nucleocapsid proteins: a viral strategy for immunosuppression?;npj Viruses;2024-09-02

2. Cell-Surface RNA Associates with Heparan Sulfate and RNA-Binding Proteins to Modulate Receptor-Ligand Interactions;2024-07-24

3. Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan‐1 expression;Molecular Oncology;2024-05-21

4. A Conditionally Activated Cytosol-Penetrating Antibody for TME-Dependent Intracellular Cargo Delivery;Antibodies;2024-05-02

5. A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain VL and an RNA hydrolyzing scFv;Frontiers in Microbiology;2024-04-19